L-Cetriver Syrup contains Levocetirizine 2.5 mg, a third-generation non-sedating antihistamine used primarily for the symptomatic relief of allergic conditions. Levocetirizine is the active enantiomer of cetirizine and exhibits selective antagonism of peripheral H1 histamine receptors, thereby inhibiting the effects of histamine released during allergic reactions. This medication is indicated for the treatment of allergic rhinitis, including seasonal and perennial types, as well as chronic idiopathic urticaria characterized by itching and hives. L-Cetriver Syrup offers rapid onset of action and sustained relief from symptoms such as sneezing, nasal congestion, rhinorrhea, and pruritus. The syrup formulation is particularly suitable for pediatric patients or individuals who have difficulty swallowing tablets. It is generally well tolerated, with a low incidence of sedation and anticholinergic side effects compared to first-generation antihistamines. Common adverse effects may include headache, dry mouth, and fatigue, though these are typically mild and transient. Dosage should be individualized based on age and clinical response, and caution is advised in patients with renal impairment. L-Cetriver Syrup should be used under medical supervision, particularly in children under six years of age, pregnant or lactating women, and patients with pre-existing medical conditions.